Jump to main content.

Economic Analysis for Final Effluent Guidelines and Standards for the Pharmaceutical Industry, Draft Report.

Quick Links

EPA Office

Ref. Number

Document Type

Title (Downloadable)

Title

Assessment Topic

This economic analysis (EA) examines compliance costs and economic impacts resulting from the U.S. Environmental Protection Agency's (EPA's) Final Effluent Limitations Guidelines and Standards for the Pharmaceutical Manufacturing Industry Point Source Category, hereinafter known as the Final Pharmaceutical Industry Effluent Guidelines. It also investigates the costs and impacts associated with an air rule requiring Maximum Achievable Control Technology (MACT) to control air emissions, both separately and together with the Final Pharmaceutical Industry Effluent Guidelines.

Descriptors:
Date:
Reference #:
1998
W.98.8 E
Availability:
Yes
EPA Office:
Office of Water
Office Suboffice:
No suboffice specified
Office Division:
Environmental Analysis Division
EPA Author:
Anderson, William
Document Type:
Economic Impact Assessment
Contractors:
Eastern Research Group, Inc.
Document Status:
Draft
Pages:
250

Local Navigation


Jump to main content.